Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Photosensitivity Disorders × Diclofenac × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 11 Pain 2 Lymphoma, Follicular 2 Breast Neoplasms 2 Acute Pain 2 Photosensitivity Disorders 1 Non-melanoma Skin Cancer 1 Neurofibromatosis 1 1 Neoplasms 1 Hand-Foot Syndrome 1 Carcinoma, Basal Cell 1

Interventions

Dihematoporphyrin Ether 1 Diclofenac 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00204542 2011-08-19

Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head

University Hospital Tuebingen

Phase 4 Completed

Photosensitivity Disorders, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡